Titan Biotech sets Sep 29 for 34th AGM and final dividend record date
- Titan Biotech schedules its 34th AGM for September 29, 2026
- Record date for final dividend entitlement set at September 22, 2026
- Book closure period runs from September 23 to September 29, 2026
- Remote e-voting window opens on September 26 and closes on September 28
*this image is generated using AI for illustrative purposes only.
Titan Biotech has scheduled its 34th Annual General Meeting (AGM) for September 29, 2026. The company also fixed September 22, 2026, as the record date to determine shareholder eligibility for the final dividend for FY26.
The meeting will be held via Video Conferencing or Other Audio Visual Means at 3:00 pm. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Register of Members and Share Transfer Books will remain closed from September 23, 2026, through September 29, 2026.
Key Dates
| Event | Date | Time |
|---|---|---|
| Record Date | September 22, 2026 | - |
| Book Closure Start | September 23, 2026 | - |
| Book Closure End | September 29, 2026 | - |
| AGM Date | September 29, 2026 | 3:00 pm |
E-Voting Schedule
Shareholders can cast their votes remotely during the designated window. The cut-off date for e-voting eligibility aligns with the record date.
| Particulars | Date and Time |
|---|---|
| Cut-off Date for E-voting | September 22, 2026 |
| Remote E-voting Start | September 26, 2026 at 10:00 am |
| Remote E-voting End | September 28, 2026 at 5:00 pm |
Charanjit Singh, Company Secretary and Compliance Officer, confirmed these details in a communication to the BSE on September 3, 2026.
Historical Stock Returns for Titan Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | +15.00% | +4.15% | +97.80% | +220.19% | +543.92% |
What specific financial performance metrics or strategic initiatives are expected to be highlighted during Titan Biotech's FY26 AGM?
How might the final dividend payout for FY26 compare to previous years, and what does this signal about the company's cash flow health?
Are there any anticipated changes to the board of directors or management team that shareholders should prepare for at the upcoming meeting?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
